Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a pharmaceutical company engages in provision of development and commercialization of medical products.

It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.

It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems.

The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.


Sales per Businesses
20152016Delta
CAD (in Million)%CAD (in Million)%
Cardiovascular Therapies26.75100%33.46100% +25.08%
Sales per Regions
20152016Delta
CAD (in Million)%CAD (in Million)%
Europe13.5350.6%14.4843.3% +7.08%
Rest of World13.2349.4%18.9856.7% +43.5%
Managers
NameAgeSinceTitle
William L. Hunter, MD532007President, Chief Executive Officer & Director
William James O'Shea672014Chairman
Sheila M. Grant, MBA-2003Chief Operating Officer
Justin A. Renz MBA, CPA452017Chief Financial Officer
Richard M. Glickman, PhD592006Lead Independent Director
Mark H. N. Corrigan, MD592015Director
Arthur H. Willms772015Independent Director
Robert James Meyer, MD-2015Director
Jennifer Archibald-2006Chief Business Operations Officer
Steen Juul-Möller MD, PhD-2013Medical Director-Europe
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 31,927,294 31,337,709 98.2% 0 0.0% 98.2%
Shareholders
NameEquities%
Westfield Capital Management Co. LP 4,894,948 15.4%
Putnam Investment Management LLC 3,438,484 10.8%
Stonepine Capital Management LLC 3,158,816 9.91%
Clough Capital Partners LP 2,958,415 9.28%
Tamarack Advisers LP 1,825,000 5.73%
Rock Springs Capital Management LP 1,200,000 3.76%
William L. Hunter, MD 614,304 1.93%
AlphaOne Investment Services LLC 550,712 1.73%
Sabby Capital LLC 273,010 0.86%
Renaissance Technologies LLC 253,413 0.80%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP46.97%138
BIOGEN INC-4.03%53 198
CSL LIMITED31.55%44 709
ALEXION PHARMACEUTICAL..-20.15%21 939
GRIFOLS SA31.81%17 451
BIOMARIN PHARMACEUTICA..6.23%15 355
CHONGQING ZHIFEI BIOLO..--.--%4 238
3SBIO INC45.00%3 589
ABCAM PLC27.90%2 564
JIANGXI BOYA BIO-PHARM..--.--%2 404
HUGEL INC--.--%1 328
BIOTEST AG71.38%1 071
PHARMA MAR SA53.51%1 033
PROMETIC LIFE SCIENCES..-10.53%1 015
ANIKA THERAPEUTICS INC-5.66%677
SYROS PHARMACEUTICALS ..22.78%402
CHEMOCENTRYX INC-6.76%332
SYNDAX PHARMACEUTICALS..80.20%236
STRONGBRIDGE BIOPHARMA..95.83%166
MEDIWOUND LTD51.77%153
KADMON HOLDINGS INC-54.21%128
Sector Biopharmaceuticals
Cardiome Pharma Corp : Connections
Zalicus Pharmaceuticals Ltd.
Brighton Biotech, Inc.
Blackthorn Therapeutics, Inc.
Quartet Medicine, Inc.
Trevi Therapeutics, Inc.
Kyowa Kirin International Plc
Michael Smith Foundation for Health Research
Richardson Capital Ltd.
Premier's Technology Council
British Columbia Lottery Corp.
Synereca Pharmaceuticals, Inc.
The 2010 Games Operating Trust
Pamlico BioPharma, Inc.
Pacific Autism Family Centre Foundation
Vancouver Symphony Orchestra
enGene, Inc.
MedGenesis Therapeutix, Inc.
The Vancouver Symphony Foundation
Vida Pharmaceuticals Pvt Ltd.
Advanced Applied Physics Solutions, Inc.
Kearny Venture Partners
Virginia Center For Translational & Regulatory Sciences
Company contact information
Cardiome Pharma Corp.
1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2017 People , Fundamentals and Ownership